Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
16.33
+1.60 (10.86%)
At close: Aug 14, 2026, 4:00 PM EDT
16.87
+0.54 (3.28%)
After-hours: Aug 14, 2026, 7:37 PM EDT
Climb Bio Employees
As of December 31, 2025, Climb Bio had 29 total employees, including 28 full-time and 1 part-time employees. The number of employees increased by 11 or 61.11% compared to the previous year.
Employees
29
Change (1Y)
11
Growth (1Y)
61.11%
Revenue / Employee
n/a
Profits / Employee
-$1,987,034
Market Cap
937.93M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 11 | 61.11% | 28 | 1 |
| Dec 31, 2024 | 18 | 7 | 63.64% | 17 | 1 |
| Dec 31, 2023 | 11 | -32 | -74.42% | 9 | 2 |
| Dec 31, 2022 | 43 | 12 | 38.71% | 30 | 13 |
| Sep 30, 2022 | 43 | 15 | 53.57% | 43 | 0 |
| Jun 30, 2022 | 41 | 16 | 64.00% | 41 | 0 |
| Mar 31, 2022 | 37 | 15 | 68.18% | 37 | 0 |
| Dec 31, 2021 | 31 | 9 | 40.91% | 19 | 12 |
| Sep 30, 2021 | 28 | - | - | 28 | 0 |
| Jun 30, 2021 | 25 | - | - | 25 | 0 |
| Mar 31, 2021 | 22 | - | - | 13 | 9 |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Geron | 258 |
| Olema Pharmaceuticals | 150 |
| Solid Biosciences | 121 |
| Janux Therapeutics | 113 |
| Odyssey Therapeutics | 100 |
| Annexon | 92 |
| Theravance Biopharma | 90 |
CLYM News
- 9 days ago - Climb Bio price target raised to $25 from $17 at Truist - TheFly
- 10 days ago - Climb Bio reports Q2 EPS (18c), consensus (21c) - TheFly
- 10 days ago - Climb Bio Earnings release: Q2 2026 - Filings
- 10 days ago - Climb Bio Quarterly report: Q2 2026 - Filings
- 10 days ago - Climb Bio Slides: Investor presentation - Filings
- 13 days ago - Climb Bio initiated with an Outperform at RBC Capital - TheFly
- 2 months ago - Climb Bio price target raised to $20 from $19 at BTIG - TheFly
- 2 months ago - Climb Bio announces initial data from budoprutug study at EHA - TheFly